Gmo Us Valuation
| GMCQX Fund | USD 12.57 0.02 0.16% |
At this time, the entity appears to be undervalued. Gmo Equity Allocation retains a regular Real Value of $13.84 per share. The prevalent price of the fund is $12.57. We determine the value of Gmo Equity Allocation from evaluating fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we encourage acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will come together.
Undervalued
Today
Please note that Gmo Us' price fluctuation is very steady at this time. At this time, the entity appears to be undervalued. Gmo Equity Allocation retains a regular Real Value of $13.84 per share. The prevalent price of the fund is $12.57. We determine the value of Gmo Equity Allocation from evaluating fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we encourage acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will come together.
Since Gmo Us is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Gmo Mutual Fund. However, Gmo Us' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 12.57 | Real 13.84 | Hype 12.57 | Naive 12.8 |
The intrinsic value of Gmo Us' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Gmo Us' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Gmo Equity Allocation helps investors to forecast how Gmo mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Gmo Us more accurately as focusing exclusively on Gmo Us' fundamentals will not take into account other important factors: Gmo Us Total Value Analysis
Gmo Equity Allocation is currently projected to have takeover price of 0 with market capitalization of 0, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Gmo Us fundamentals before making investing decisions based on enterprise value of the companyGmo Us Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Gmo suggests not a very effective usage of assets in March.About Gmo Us Valuation
Our relative valuation model uses a comparative analysis of Gmo Us. We calculate exposure to Gmo Us's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Gmo Us's related companies.Under normal circumstances, the fund invests directly and indirectly at least 80 percent of its assets in equities tied economically to the United States. GMO US is traded on NASDAQ Exchange in the United States.
Other Information on Investing in Gmo Mutual Fund
Gmo Us financial ratios help investors to determine whether Gmo Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gmo with respect to the benefits of owning Gmo Us security.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |